Clark said on Monday it plans to acquire Band-Aid maker Kenvue, even as the latter company faces thousands of lawsuits ...

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...

Aid maker Kenvue , even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based ...

Kenvue, which was spun out of Johnson & Johnson (NYSE: JNJ) in 2023, has faced persistent headwinds since its public debut. Its shares have fallen roughly 35% from the IPO price amid lawsuits and ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

A US drug giant hit by Donald Trump’s claims linking its paracetamol brand to an increased risk of autism has been bought for ...

About half to three-quarters of expectant mothers experience pain during pregnancy that is largely untreated, contributing to ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.

About half to three-quarters of expectant mothers experience pain during pregnancy that is largely untreated, contributing to ...